SFI
TMCI icon

Susquehanna Fundamental Investments’s Treace Medical Concepts TMCI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,272
Closed -$490K – 754
2025
Q2 		$490K Sell
83,272
-53,135
-39% -$346K 0.01% 552
2025
Q1 		$1.14M Sell
136,407
-1,337
-1% -$12K 0.02% 658
2024
Q4 		$1.02M Buy
+137,744
New +$922K 0.01% 700

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's TMCI Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 83,272 shares — an estimated $490K sold.

Susquehanna Fundamental Investments first reported a position in TMCI in Q4 2024 and held it in 3 quarters. The position peaked at $1.14M in Q1 2025. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Susquehanna Fundamental Investments reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 83,272 Treace Medical Concepts shares in Q3 2025, an estimated $490K.
  • Susquehanna Fundamental Investments first reported a position in Treace Medical Concepts in Q4 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Treace Medical Concepts position peaked at $1.14M in Q1 2025.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.